Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128834) titled 'Exploration of the Therapeutic Value and Underlying Mechanisms of Natural Plant-Derived Medicines in Regulating Metabolic Disorders During the Menopausal Transition' on July 27.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Perimenopausal syndrome associated with metabolic disorders
Intervention:
Sangzhi Alkaloids Group:Sangzhi Alkaloids Tablets
Menopausal Hormone Therapy Group:Femoston 2/10
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-30
Target Sample Size: Sangzhi Alkaloids Group:35;Menopa...